Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men

Neuropeptide Ys (NPYs) contribute to sympathetic‐adreno stimulation: NPY1‐36 potentiates the effects of catecholamines (CATs), whereas NPY3‐36 inhibits CAT release. We sought to investigate whether inhibiting dipeptidyl‐peptidase‐4 (DPP4), cleaving NPY1‐36 into NPY3‐36, leads to increased NPY1‐36 po...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdillon, Nicolas, Eugster, Philippe J., Vocat, Céline, Nguyen, Toan, Wuerzner, Gregoire, Grouzmann, Eric, Millet, Grégoire P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718941/
https://www.ncbi.nlm.nih.gov/pubmed/36461653
http://dx.doi.org/10.14814/phy2.15515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718941/
https://www.ncbi.nlm.nih.gov/pubmed/36461653
http://dx.doi.org/10.14814/phy2.15515

Ejemplares similares